We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Human Granulocytic Anaplasmosis Confirmed by Molecular Assay

By LabMedica International staff writers
Posted on 26 Mar 2012
Human granulocytic anaplasmosis (HGA) is a tick-borne infection, yet few clinical cases have been diagnosed by a positive polymerase chain reaction (PCR) assay. More...


Subsequent seroconversion against the antigen of the causative intraerythrocytic agent, Anaplasma phagocytophilum, would fulfill the epidemiologic, clinical, and biological criteria for HGA, which is characterized by an acute, nonspecific febrile illness.

At the Hôpitaux Universitaires de Strasbourg (France), 15 patients presented with a febrile syndrome with a recent history of tick bites or exposures to ticks were tested for HGA, during the period June to September 2009. Whole blood samples with ethylenediaminetetraacetic acid (EDTA) were systematically collected for blood smear and specific PCR assay during the febrile phase of the disease. For serologic testing, two sera were also collected: the first during the acute phase and the second two to three weeks afterwards, during the convalescent phase.

DNA was extracted from whole-blood samples and real-time PCR was performed on the ABI Prism 7000 SDS (Applied Biosystems; Foster City, CA, USA). Serologic diagnosis of infection with A. phagocytophilum was made by immunofluorescent antibody test (IFA) (Focus Diagnostics, Cypress, CA, USA). Serum specimens with immunoglobulin M (IgM) titers of equal or greater than 1:40 and IgG titers equal to or greater than 1:64 were considered positive. Blood smears were obtained from whole blood samples, stained with May-Grünwald-Giemsa and examined for the presence of morulae within the cytoplasm of neutrophils

Molecular testing using the major surface protein 2 (msp2)/p44 gene yielded positive results in the acute-phase blood of three of the 15 patients tested. For the 12 patients with negative PCR assay, microscopic examination was negative and no specific antibodies were detected in acute-phase serum. Laboratory findings were available for 6 patients among the 12 with a negative PCR assay; all these 6 presented leucopenia, thrombocytopenia, and increased levels of liver enzymes. For the three patients with positive PCR results, examination of peripheral blood smears revealed cytoplasmic inclusions suggestive of A. phagocytophilum morulae and elevated serum levels of liver enzymes.

The authors concluded that a specific PCR assay on EDTA anticoagulated blood may be the diagnostic test of choice for HGA during the first two weeks following the onset of symptoms, allowing a faster diagnosis than serology. HGA should be included in the differential diagnosis of patients presenting febrile illness associated with bicytopenia, elevated rates of liver enzymes, increased C-reactive protein values, and whose medical history reveals recent exposure to ticks. The study was published in the March 2012 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Hôpitaux Universitaires de Strasbourg
Applied Biosystems
Focus Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automated Urinalysis Solution
UN-9000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.